<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04017403</url>
  </required_header>
  <id_info>
    <org_study_id>PAPOCD</org_study_id>
    <nct_id>NCT04017403</nct_id>
  </id_info>
  <brief_title>Probiotics Attenuate Postoperative Cognition Decline</brief_title>
  <official_title>Probiotics Oral Administration Attenuate Postoperative Cognition Decline in Elderly Orthopedic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate whether perioperative probiotics can reduce the
      incidence of postoperative cognitive dysfunction and postoperative delirium.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 15, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of POD 7 days after surgery</measure>
    <time_frame>One day after surgery to the seventh day after surgery</time_frame>
    <description>Use the CAM scale to assess whether a patient has postoperative delirium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of POCD 7days after surgery</measure>
    <time_frame>The seventh day after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of POCD 1 month after operation</measure>
    <time_frame>One month after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Necrosis of Femoral Head</condition>
  <condition>Knee Osteoarthritis</condition>
  <condition>Fracture of Neck of Femur</condition>
  <condition>Lumbar Disc Herniation</condition>
  <arm_group>
    <arm_group_label>Probiotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The probiotic group was treated with Bifidobacterium tripleis,one day before surgery to the sixth day after surgerythe drug is taken orally, 4 capsules at a time, 2 times a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group was given the same package of placebo,one day before surgery to the sixth day after surgery. The drug is taken orally, 4 capsules at a time, 2 times a day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bifidobacterium triple live capsule</intervention_name>
    <description>Bifidobacterium triple live capsules, indications for acute and chronic diarrhea and constipation caused by intestinal flora imbalance, can also be used for the treatment of mild to moderate acute diarrhea, chronic diarrhea and indigestion, bloating, and adjuvant treatment of intestinal flora Endotoxemia caused by disorders.</description>
    <arm_group_label>Probiotic group</arm_group_label>
    <other_name>Peifei Kang Capsule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Placebos were administrated as same as the bifidobacterium live capsule</description>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. . Age is greater than or equal to 65 years old

          2. . Can communicate normally

          3. . Selective knee ankle, hip replacement or lumbar open reduction and internal fixation
             under general anesthesia

          4. . ASA graded at I-II level

          5. . Patient or family informed consent

        Exclusion Criteria:

          1. . Have a brain disease, or have a history of brain disease

          2. .MMSE check of less than 24 points.

          3. . History of neurological and psychological disorders including AD, stroke, psychosis

          4. . Serious hearing or visual impairment

          5. . Preoperative systolic blood pressure &gt;190mmhg, or diastolic blood pressure &gt;100mmhg

          6. . The patient or family refuses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>su diansan</last_name>
    <role>Study Chair</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>tang ying, Bachelor</last_name>
    <phone>13918859887</phone>
    <phone_ext>18616514088</phone_ext>
    <email>421941497@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>su diansan, Doctor</last_name>
    <phone>18616514088</phone>
    <phone_ext>18616514088</phone_ext>
    <email>184872238@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Diansan Su</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 9, 2019</study_first_submitted>
  <study_first_submitted_qc>July 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>July 10, 2019</last_update_submitted>
  <last_update_submitted_qc>July 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>postoperative cognitive dysfunction</keyword>
  <keyword>postopeartive delirium</keyword>
  <keyword>Probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Femoral Neck Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

